Gene Therapy Shows 75% Halt in Huntington's Disease Progression

Source: Preliminary but promising gene therapy shows 75% reduction in Huntington's disease progression (2025-09-25)

A new preliminary gene therapy has demonstrated promising results, reducing the progression of Huntington's disease by 75%. Researchers are optimistic about its potential to significantly improve patient outcomes and advance treatment options for this neurodegenerative disorder. While still in early stages, the therapy's success marks a major breakthrough in Huntington's research. Experts are closely monitoring further developments, hoping this approach will lead to more effective and accessible treatments in the future.

More recent coverage

• Website Faces Technical Difficulties, Users Encounter Errors
• ICE Clarifies Detainee Death Reporting Procedures
• A$AP Rocky Opens Up on Trial, Music, and Family
• Arthur Guinness: The Man Behind the Iconic Brand
• New Technology Boosts Renewable Energy Efficiency
• Japan Participates in UN General Assembly Debate
• Leonardo DiCaprio Embraces "The Dude" Era